Publication | Closed Access

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaHematologyMyeloid NeoplasiaCytarabine ChemotherapyAcute Myeloid LeukaemiaFirst-line TreatmentPharmacotherapyOncologyRadiation OncologyCancer ResearchHealth Sciences